Magnesium, biomaterials and additive manufacturing are among the technologies CEOs note are driving implant innovation. Details on how OEMs are adopting these technologies were discussed at the ORTHOWORLD Symposium. Read on.
The Directors of the Division of Orthopedic Devices and the Division of Manufacturing and Quality will help you navigate 510(k)s, 483s, UDI and risk management challenges. Bring your questions!
Taper junction has come into the spotlight as a major source of hip joint failure. Tools such as coordinate measuring machines are being adopted to provide fast, detailed and accurate measurements of taper geometry during R&D and manufacturing.Read on.
Key focus areas for FDA in 2015 include: CAPA+2, UDI implementation and premarket/postmarket controls enforcement. Ensure you're prepared for FDA's plans and upcoming changes in the year ahead. Read on.
Please confirm your subscription to this eNewsletter.
